Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Latest Market Insights for the Migraine Drugs Industry?

The market size for migraine medications has gradually expanded over the past few years. The market, previously worth $5.38 billion in 2024, is projected to escalate to $5.71 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.2%. The historical growth of this sector can be accredited to progressive strides made in drug formulations, heightened consciousness and diagnosis, stress and lifestyle factors, the proliferation of generic drugs, and the advent of CGRP inhibitors.

Forecasts suggest robust expansion in the migraine medication market in the coming years. It is projected to skyrocket to “$7.08 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 5.5%. The surge during the anticipated period can be credited to personalized medical applications, distanced healthcare consultations, health policy and insurance inclusions, mounting global migraine implications, and combined treatment methods. Dominant developments anticipated during this period encompass targeted therapy solutions, distanced medical consultations, patient-focused methods, digital health treatments, biosimilar application in migraine management, and clinical investigations and experiments.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13484&type=smp

What Forces Are Driving The Growth Of The Migraine Drugs Industry?

The escalating number of females worldwide is projected to bolster the progress of the migraine drugs market in the coming years. The term ‘female population’ pertains to all females of different age groups residing within a country or region during a particular timeframe. Migraines are notably more prevalent in females than males, a situation attributed to a mix of genetic, hormonal, and environmental aspects. As an example, the World Population Prospects 2022, disseminated by the US-based intergovernmental organization United Nations, suggests that the global female populace in 2022 is likely around 4.00 billion, accounting for 49.75% of the global populace. It is furthermore projected that the number of females will surpass males by 2049. Consequently, the surge in the female populace is fueling the expansion of the migraine drugs market.

The migraine drugs market covered in this report is segmented –

1) By Drug Class: Triptans, Betablockers, Angiotensin Blockers, Tricyclics, Anticonvulsants

2) By Route of Administration: Oral, Injectable, Other Routes

3) By End-User: Hospitals And Clinics, Retail Pharmacy, Online Pharmacy, Other End Users

Subsegments:

1) By Triptans: Sumatriptan, Rizatriptan, Zolmitriptan, Eletriptan

2) By Beta Blockers: Propranolol, Metoprolol, Timolol

3) By Angiotensin Blockers: Candesartan, Losartan

4) By Tricyclics: Amitriptyline, Nortriptyline

5) By Anticonvulsants: Topiramate, Valproate

Which Trends Are Redefining The Future Landscape Of The Migraine Drugs Industry?

Key players in the migraine drugs market, such as Zavzpret, are focusing on the innovation of new products to meet the needs of their patients and to maintain a competitive position in the market. Zavzpret, a nasal spray medication, has been developed to provide acute treatment for migraines in adults, with or without aura. In March 2023, Zavzpret received the endorsement of the Food and Drug Administration, a federal US agency, thus becoming the first exclusively approved zavegepant (a CGRP receptor antagonist) nasal spray for acute migraine treatment. Zavzpret is a pioneering treatment method, focusing primarily on the calcitonin gene-related peptide (CGRP). The introduction of Zavzpret offers a revolutionary treatment solution for those suffering from migraines, particularly those who experience nausea and vomiting during attacks or those at risk of cardiovascular complications due to the use of triptans.

Who Are The Primary Players Operating Across The Global Migraine Drugs Market?

Major companies operating in the migraine drugs market report are Pfizer Inc., Johnson & Johnson Services Inc., Bayer AG, Merck & Co. Inc., AbbVie Inc., AbbVie Inc., Sanofi SA, Novartis AG, AstraZeneca, Abbott Laboratories, GlaxoSmithKline plc., Eli Lilly and Company, Amgen Inc., Otsuka Holdings Co. Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Eisai Co. Ltd., Dr Reddy’s Laboratories Ltd., H. Lundbeck A/S, Amneal Pharmaceuticals Inc., Endo Pharmaceuticals Inc., Neurelis Inc., ALDER BIOPHARMACEUTICALS INC., eNeura Inc., Winston Pharmaceuticals Ltd.

https://www.thebusinessresearchcompany.com/report/migraine-drugs-global-market-report

Which Region Offers The Most Growth Potential For The Migraine Drugs Market Through 2029?

North America was the largest region in the migraine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the migraine drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13484&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model